Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and “Insulin-Resistant” T−455C APOC3 Gene Polymorphism in Heart Disease Patients: Example of Gene-Diet Interaction
Author(s) -
Oliviero Olivieri,
Nicola Martinelli,
Marco Sandri,
Antonella Bassi,
Patrizia Guarini,
Elisabetta Trabetti,
Francesca Pizzolo,
Domenico Girelli,
Simonetta Friso,
Pier Franco Pignatti,
Roberto Corrocher
Publication year - 2004
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2004.040477
Subject(s) - docosahexaenoic acid , polyunsaturated fatty acid , medicine , endocrinology , population , apolipoprotein b , genotype , triglyceride , biology , fatty acid , cholesterol , biochemistry , gene , environmental health
Apolipoprotein C-III (apo C-III) is a marker of cardiovascular disease risk associated with triglyceride (TG)-rich lipoproteins. The T-455C polymorphism in the insulin-responsive element of the APOC3 gene influences TG and apo C-III concentrations. Long-chain n-3 polyunsaturated fatty acids (PUFAs) contained in fish have well-known apo C-III-lowering properties.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom